摘要:
Shredded whole grain products, such as ready-to-eat cereals, and sweet and savory snacks, such as whole grain shredded corn chips are continuously produced by pelletizing agglomerates of cooked, tempered, whole cereal grain particles. Cooked whole grains, such as corn and other non-gluten or low-gluten containing grains have a tendency to become hard and rubbery after cooking during the cooling and tempering process. The pelletization results in the production of whole grain pellets having a soft, pliable texture, which are shreddable into continuous net-like sheets on a mass production basis. The pelletizing may be at a pressure of about 200 psig to about 600 psig, preferably from about 400 psig to about 500 psig. The pelletizing temperature may be controlled to provide a pellet temperature of about 80° F. to about 120° F., preferably from about 90° F. to about 110° F., upon exiting the pelletizer.
摘要:
Snow-making apparatus comprises the combination of a bulk water nozzle for projecting a spray of water particles into the air, and a plurality of nucleators for injecting ice particles (nuclei) into the spray to provide nucleation sites about the water particles freeze and form snow particles or crystals. Each nucleator comprises discrete nozzles for respectively projecting air and water particles to a location at which they collide in the open air to form ice particles. Because the ice particles are formed "externally" of any housing, the "freeze-up" problem associated with the "internal-mix" nucleators of the prior art is avoided. Preferably, each of the water nozzles of the external mix nucleators projects a relatively thin "sheet" of water which collides with a similar pattern of compressed air which acts (a) to break-up the water into relatively tiny droplets (e.g. 5-100 microns in size) which quickly freeze to form the ice nuclei of about the same size, and (b) to project a relatively flat pattern of ice nuclei towards the bulk water spray.
摘要:
The invention relates to modulating the SIRPα-CD47 interaction in order to treat hematological cancer and compounds therefor. In some embodiments, there is provided methods and uses of SIRPα polypeptides, fragments and fusion proteins for treating hematological cancer, preferably human acute myeloid leukemia.